Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing IκB kinase-dependent NF-κB activation

Molecules and Cells

Volumn 16, Issue 1, 2003, Pages 97-105

  Lee, Seon Jin ^a   Bai, Se Kyung ^a   Lee, Kwang Soon ^a   Namkoong, Seung ^a   Na, Hee Jun ^a   Ha, Kwon Soo ^a   Han, Jeong A ^a   Yim, Sung Vin ^a   Chang, Kwang ^a   Kwon, Young Guen ^a   Lee, Sung Ki ^a   Kim, Young Myeong ^a  

^a Kangwon National University   (South Korea)

Author keywords

Cytokine; Inflammation; NF B; Nitric Oxide; Reactive Oxygen Species

Indexed keywords

ASTAXANTHIN; CYCLOOXYGENASE 2; HYDROGEN PEROXIDE; I KAPPA B ALPHA; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; BETA CAROTENE; CHUK PROTEIN, MOUSE; DRUG DERIVATIVE; I KAPPA B; IKBKB PROTEIN, MOUSE; IKBKE PROTEIN, MOUSE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1; ISOENZYME; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, MOUSE; PROSTAGLANDIN SYNTHASE; PROTEIN SERINE THREONINE KINASE; XANTHOPHYLL;

ANIMAL CELL; ARTICLE; CELL LINE; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME REPRESSION; GENE EXPRESSION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; ACTIVE TRANSPORT; ANIMAL; BAGG ALBINO MOUSE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROMOTER REGION;

ANIMALIA;

ACTIVE TRANSPORT, CELL NUCLEUS; ADJUVANTS, IMMUNOLOGIC; ANIMALS; BETA CAROTENE; CELL LINE; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; GENE EXPRESSION REGULATION; I-KAPPA B KINASE; I-KAPPA B PROTEINS; INTERLEUKIN-1; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROMOTER REGIONS (GENETICS); PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA; XANTHOPHYLLS;

EID: 3042742915     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Baeuerle, P. A. and Baichwal, V. R. (1997) NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol. 65, 111-137.
2. Bennedsen, M., Wang, X., Willen, R., Wadstrom, T., and Andersen, L. P. (1999) Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol. Lett. 70, 185-189.
3. Berg, J., Fellier, H., Christoph, T., Grarup, J., and Stimmeder, D. (1999) The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro. Inflamm. Res. 48, 369-379.
4. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fitzner, J. N., Johnson, R. S., Paxton, R. J., March, C. J., and Cerretti, D. P. (1997) A metalloproteinase disintegrin that releases tumour necrosis factor-α from cells. Nature 385, 729-733.
5. Butcher, B. A., Kim, L., Johnson, P. F., and Denkers, E. Y. (2001) Toxoplasma gondii tachyzoites inhibit proinflammatory cytokine induction in infected macrophages by preventing nuclear translocation of the transcription factor NF-κB. J. Immunol. 167, 2193-2201.
6. Castrillo, A., de Las, H. B., Hortelano, S., Rodriguez, B., Villar, A., and Bosca, L. (2001) Inhibition of the nuclear factor kappa B (NF-κB) pathway by tetracyclic kaurene diterpenes in macrophages. Specific effects on NF-κB-inducing kinase activity and on the coordinate activation of ERK and p38 MAPK. J. Biol. Chem. 276, 15854-15860.
7. Chang, Y. H., Lee, S. T., and Lin, W. W. (2001) Effects of cannabinoids on LPS-stimulated inflammatory mediator release from macrophages: involvement of eicosanoids. J. Cell. Biochem. 81, 715-723.
8. Cunha, F. Q., Assreuy, J., Moss, D. W., Rees, D., Leal, L. M., Moncada, S., Carrier, M., O'Donnell, C. A., and Liew, F. Y. (1994) Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-α and IL-1β. Immunology 81, 211-215.
9. de Martin, R., Vanhove, B., Cheng, Q., Hofer, E., Csizmadia, V., Winkler, H., and Bach, F. H. (1993) Cytokine-inducible expression in endothelial cells of an IκB-α-like gene is regulated by NF-κB. EMBO J. 12, 2773-2779.
10. de Vera, M. E., Shapiro, R. A., Nussler, A. K., Mudgett, J. S., Simmons, R. L., Morris, S. M. Jr., Billiar, T. R., and Geller, D. A. (1996) Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter. Proc. Natl. Acad. Sci. USA 93, 1054-1059.
11. Dichtl, W., Nilsson, L., Goncalves, I., Ares, M. P., Banfi, C., Calara, F., Hamsten, A., Eriksson, P., and Nilsson, J. (1999) Very low-density lipoprotein activates nuclear factor-κB in endothelial cells. Circ. Res. 84, 1085-1094.
12. Dinarello, C. A. (2001) Anti-cytokine therapies in response to systemic infection. J. Investig. Dermatol. Symp. Proc. 6, 244-250.
13. Feldmann, M., Brennan, F. M., Williams, R. O., Elliott, M. J., and Maini, R. N. (1995) Cytokine expression and networks in rheumatoid arthritis: rationale for anti-TNF-α antibody therapy and its mechanism of action. J. Inflamm. 47, 90-96.
14. 2 and TNF-α by nitric oxide and LPS-activated RAW 264.7 cells. Cytokine 19, 175-180.
15. Guslandi, M. (1998) Nitric oxide and inflammatory bowel diseases. Eur. J. Clin. Invest. 28, 904-907.
16. 2 and nitric oxide in inducible nitric oxide synthase expression in macrophages. Nitric Oxide 5, 504-513.
17. Kagari, T., Doi, H., and Shimozato, T. (2002) The importance of IL-1β and TNF-α, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J. Immunol. 169, 1459-1466.
18. Keifer, J. A., Guttridge, D. C., Ashburner, B. P., and Baldwin, A. S. Jr (2001) Inhibition of NF-κB activity by thalidomide through suppression of IκB kinase activity. J. Biol. Chem. 276, 22382-22387.
19. Kiemer, A. K., Hartung, T., Huber, C., and Vollmar, A. M. (2003) Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-κB pathway. J. Hepatol. 38, 289-297.
20. Kim, Y. M., de Vera, M. E., Watkins, S. C., and Billiar, T. R. (1997) Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-α-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem. 272, 1402-1411.
21. Kim, K. M., Chun, S. B., Koo, M. S., Choi, W. J., Kim, T. W., Kwon, Y. G., Chung, H. T., Billiar, T. R., and Kim, Y. M. (2001) Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine. Free Radical Biol. Med. 30, 747-756.
22. Koo, M. S., Kwo, Y. G., Park, J. H., Choi, W. J., Billiar, T. R., and Kim, Y. M. (2002) Signaling and function of caspase and c-jun N-terminal kinase in cisplatin-induced apoptosis. Mol. Cells 13, 194-201.
23. Kurashige, M., Okimasu, E., Inoue, M., and Utsumi, K. (1990) Inhibition of oxidative injury of biological membranes by astaxanthin. Physiol. Chem. Phys. Med. NMR 22, 27-38.
24. Leach, M., Hamilton, L. C., Olbrich, A., Wray, G. M., and Thiemermann, C. (1998) Effects of inhibitors of the activity of cyclooxygenase-2 on the hypotension and multiple organ dysfunction caused by endotoxin: a comparison with dexamethasone. Br. J. Pharmacol. 124, 586-592.
25. Li, Q. and Verma, I. M. (2002) NF-κB regulation in the immune system. Nat. Rev. Immunol. 2, 725-734.
26. Makarov, S. S. (2000) NF-κB as a therapeutic target in chronic inflammation: recent advances. Mol. Med. Today 6, 441-448.
27. Ma, Q. and Kinneer, K. (2002) Chemoprotection by phenolic antioxidants. Inhibition of tumor necrosis factor-α induction in macrophages. J. Biol. Chem. 277, 2477-2484.
28. Mathison, J. C., Wolfson, E., and Ulevitch, R. J. (1988) Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J. Clin. Invest. 81, 1925-1937.
29. 2-dependent production of interleukin-11 in rheumatoid synovial fibroblasts. Arthritis. Rheum. 11, 2004-2013.
30. Mortensen, A., Skibsted, L. H., Sampson, J., Rice-Evans, C., and Everett, S. A. (1997) Comparative mechanisms and rates of free radical scavenging by carotenoid antioxidants. FEBS Lett. 418, 91-97.
31. Neuzil, J., Schroder, A., von Hundelshausen, P., Zernecke, A., Weber, T., Gellert, N., and Weber, C. (2001) Inhibition of inflammatory endothclial responses by a pathway involving caspase activation and p65 cleavage. Biochemistry 40, 4686-4692.
32. Pahan, K., Sheikh, F. G., Namboodiri, A. M., and Singh, I. (1998) N-acetyl cysteine inhibits induction of NO production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radical Biol. Med. 24, 39-48.
33. Pan, M. H., Lin-Shiau, S. Y., Ho, C. T., Lin, J. H., and Lin, J. K. (2000) Suppression of lipopolysaccharide-induced nuclear factor-κB activity by theaflavin-3,3′-digallate from black tea and other polyphenols through down-regulation of IκB kinase activity in macrophages. Biochem. Pharmacol. 59, 357-367.
34. Piaggio, E., Sanceau, J., Revelli, S., Bottasso, O., Wietzerbin, J., and Serra, E. (2001) Trypanocidal drug benznidazole impairs lipopolysaccharide induction of macrophage nitric oxide synthase gene transcription through inhibition of NF-κB activation. J. Immunol. 167, 3422-3426.
35. Pinheiro, R. M. and Calixto, J. B. (2002) Effect of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm Res. 51, 603-610.
36. Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G., and Schwarz, E. M. (2003) Mechanisms of TNF-α- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest. 111, 821-831.
37. Sanlioglu, S., Williams, C. M., Samavati, L., Butler, N. S., Wang, G., McCray, P. B., Jr Ritchie, T. C., Hunninghake, G. W., Zandi, E., and Engelhardt, J. F. (2001) Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-α secretion through IKK regulation of NF-κB. J. Biol. Chem. 276, 30188-30198.
38. Simons, R. K., Junger, W. G., Loomis, W. H., and Hoyt, D. B. (1996) Acute lung injury in endotoxemic rats is associated with sustained circulating IL-6 levels and intrapulmonary CINC activity and neutrophil recruitment-role of circulating TNF-α and IL-β? Shock 6, 39-45.
39. Stefanovic-Racic, M., Meyers, K., Meschter, C., Coffey, J. W., Hoffman, R. A., and Evans, C. H. (1994) N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis. Rheum. 37, 1062-1069.
40. Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., and Aunins, J., et al. (1992) A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature 356, 768-774.
41. Xie, Q. (1997) A novel lipopolysaccharide-response element contributes to induction of nitric oxide synthase. J. Biol. Chem. 272, 14867-14872.
42. Xie, Q. W., Kashiwabara, Y., and Nathan, C. (1994) Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269, 4705-4708.
43. Yokoseki, O., Suzuki, J., Kitabayashi, H., Watanabe, N., Wada, Y., Aoki, M., Morishita, R., Kaneda, Y., Ogihara, T., Futamatsu, H., Kobayashi, Y., and Isobe, M. (2001) cis Element decoy against nuclear factor-κB attenuates development of experimental autoimmune myocarditis in rats. Circ. Res. 89, 899-906.